Anti-IL-33 Antibody Has a Therapeutic Effect in an Atopic Dermatitis Murine Model Induced by 2, 4-Dinitrochlorobenzene.

about

Mechanism for Initiation of Food Allergy: Dependence on skin barrier mutations and environmental allergen co-stimulation.

P2860

Q49896186-6A36FFDF-D6B5-4678-ABF3-547B97127A26

P2860

Anti-IL-33 Antibody Has a Therapeutic Effect in an Atopic Dermatitis Murine Model Induced by 2, 4-Dinitrochlorobenzene.

Item

http://www.wikidata.org/entity/Q48283294

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Anti-IL-33 Antibody Has a Ther ...... by 2, 4-Dinitrochlorobenzene.

@en

Anti-IL-33 Antibody Has a Ther ...... by 2, 4-Dinitrochlorobenzene.

@nl

type

Item

label

Anti-IL-33 Antibody Has a Ther ...... by 2, 4-Dinitrochlorobenzene.

@en

Anti-IL-33 Antibody Has a Ther ...... by 2, 4-Dinitrochlorobenzene.

@nl

prefLabel

Anti-IL-33 Antibody Has a Ther ...... by 2, 4-Dinitrochlorobenzene.

@en

Anti-IL-33 Antibody Has a Ther ...... by 2, 4-Dinitrochlorobenzene.

@nl

P1476

Anti-IL-33 Antibody Has a Ther ...... by 2, 4-Dinitrochlorobenzene.

@en

P2093

Ge Peng

http://www.w3.org/2001/XMLSchema#string

Lixia Cui

http://www.w3.org/2001/XMLSchema#string

Pengyue Liu

http://www.w3.org/2001/XMLSchema#string

Wenqing Wu

http://www.w3.org/2001/XMLSchema#string

Ying Wang

http://www.w3.org/2001/XMLSchema#string

Zhenzhen Mu

http://www.w3.org/2001/XMLSchema#string

P2860

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation

Mast cells in atopic dermatitis

Experimental atopic dermatitis depends on IL-33R signaling via MyD88 in dendritic cells.

Atopic dermatitis: new insights and opportunities for therapeutic intervention.

Allergen sensitization through the skin induces systemic allergic responses.

7,8,4'-Trihydroxyisoflavone attenuates DNCB-induced atopic dermatitis-like symptoms in NC/Nga mice.

Animal research: reporting in vivo experiments: the ARRIVE guidelines.

Therapeutic strategies in extrinsic atopic dermatitis: focus on inhibition of IL-4 as a new pharmacological approach.

Th2 Cytokines and Atopic Dermatitis.

P2888

s10753-017-0673-7

P304

154-163

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10753-017-0673-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Xiuping Han

P577

2017-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28952069

http://www.w3.org/2001/XMLSchema#string

Anti-IL-33 Antibody Has a Therapeutic Effect in an Atopic Dermatitis Murine Model Induced by 2, 4-Dinitrochlorobenzene.

about

P2860

P2860

Anti-IL-33 Antibody Has a Therapeutic Effect in an Atopic Dermatitis Murine Model Induced by 2, 4-Dinitrochlorobenzene.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698